Isala

Zwolle, Overijssel 8025 AB

0 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Disease, Non-Small Cell Lung Cancer

Studies at this site

• Double Blind Placebo Controlled Controlled Study of Adjuvant MEDI4736 In Completely Resected NSCLC — Running, not enrolling
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early
• The Evaluation of Bococizumab (PF-04950615;RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early